Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.17%
#2 Pons Pons +35.28%
#3 Purr Purr +31.14%
#4 TENDIES TENDIES +31.06%
#5 Starpower Starpower +29.73%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.67%
#7 StonkBroker StonkBroker +26.47%
#8 SkyAI SkyAI +24.19%
#9 Magma Finance Magma Finance +22.28%
#10 PondCoin PondCoin +20.95%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Celularity Inc. Celularity Inc.

Celularity Inc.

CELU
Pozycja w akcjach #28873
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to... Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing through Phase I trials for acute myeloid leukemia and Phase I/IIa trials for glioblastoma multiforme and COVID-19; and CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I for HER2+ gastric and gastroesophageal cancers. Furthermore, two mesenchymal-like adherent stromal cell candidates, APPL-001 and PDA-002 (both derived from placentas), are in pre-clinical development for Crohn's disease and facioscapulohumeral muscular dystrophy, respectively. In addition to its therapeutic development, Celularity is involved in commercial activities, offering surgical and wound care products like Biovance and Interfyl through sales and licensing agreements. The company also specializes in collecting stem cells from umbilical cords and placentas, providing storage services under its LifebankUSA brand. Founded in 2016, Celularity Inc. maintains its headquarters in Florham Park, New Jersey.
Cena akcji
$0.82
Kapitalizacja rynkowa
$23.74M
Zmiana (1 dzień)
11.31%
Zmiana (1 rok)
-77.29%
Kraj
US
Handel Celularity Inc. (CELU)

Kategoria

Healthcare
Historia ceny akcji dla Celularity Inc. (CELU)
Najwyższa cena zamknięcia: $0.71 dnia 2026-08-01

Najniższa cena zamknięcia: $97.91 dnia 2019-08-01
Historia cen akcji firmy Celularity Inc. od 2019 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -8.41%
2025 -30.04%
2024 12.55%
2023 -86.13%
2022 -72.74%
2021 -53.01%
2020 11.78%
2019 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $551.16 41.05%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 57.08%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $163.88 487.17%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.42 -19.34%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $753.28 8.59%
CH